Info
- Utilizzare la checkbox di selezione a fianco di ciascun documento per attivare le funzionalità di stampa, invio email, download nei formati disponibili del (i) record.
COVID-19: critical vaccine distribution, supply chain, program integrity, and other challenges require focused federal attention : report to congressional committees
| COVID-19: critical vaccine distribution, supply chain, program integrity, and other challenges require focused federal attention : report to congressional committees |
| Pubbl/distr/stampa | [Washington, D.C.] : , : United States Government Accountability Office, , 2021 |
| Descrizione fisica | 1 online resource (vii, 333 pages) : color illustrations |
| Soggetto topico |
COVID-19 (Disease) - Vaccination - United States - Planning
COVID-19 (Disease) - Economic aspects - United States COVID-19 (Disease) - Diagnosis - United States COVID-19 (Disease) - United States - Prevention COVID-19 (Disease) - Treatment - United States Vaccines industry - Government policy - United States Vaccines - Development - United States Public health administration - United States COVID-19 (Disease) - Diagnosis COVID-19 (Disease) - Economic aspects COVID-19 (Disease) - Prevention COVID-19 (Disease) - Treatment Expenditures, Public Public health administration Vaccines industry - Government policy |
| Formato | Materiale a stampa  |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Altri titoli varianti | COVID-19 |
| Record Nr. | UNINA-9910715226403321 |
| [Washington, D.C.] : , : United States Government Accountability Office, , 2021 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
COVID-19: HHS agencies' planned reviews of vaccine distribution and communication efforts should include stakeholder perspectives : report to congressional committees
| COVID-19: HHS agencies' planned reviews of vaccine distribution and communication efforts should include stakeholder perspectives : report to congressional committees |
| Pubbl/distr/stampa | [Washington, D.C.] : , : United States Government Accountability Office, , 2021 |
| Descrizione fisica | 1 online resource (iii, 62 pages) : color illustrations |
| Soggetto topico |
COVID-19 (Disease) - Vaccination - Government policy - United States
Vaccines industry - Government policy - United States Emergency management - United States Public health administration - United States Emergency management Public health administration Vaccines industry - Government policy |
| Soggetto genere / forma | Rules. |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Altri titoli varianti | COVID-19 |
| Record Nr. | UNINA-9910716953603321 |
| [Washington, D.C.] : , : United States Government Accountability Office, , 2021 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Examining Emergent Biosolutions' failure to protect public health and public funds : hearing before the Select Subcommittee on the Coronavirus Crisis of the Committee on Oversight and Reform, House of Representatives, One Hundred Seventeenth Congress, first session, May 19, 2021
| Examining Emergent Biosolutions' failure to protect public health and public funds : hearing before the Select Subcommittee on the Coronavirus Crisis of the Committee on Oversight and Reform, House of Representatives, One Hundred Seventeenth Congress, first session, May 19, 2021 |
| Pubbl/distr/stampa | Washington : , : U.S. Government Publishing Office, , 2021 |
| Descrizione fisica | 1 online resource (iii, 44 pages) |
| Disciplina | 4.OV 2:117-23 |
| Soggetto topico |
COVID-19 (Disease) - Vaccination - United States
COVID-19 Pandemic, 2020- - United States Vaccines industry - Government policy - United States Vaccines industry - Subsidies - United States Vaccines - United States COVID-19 (Disease) - Vaccination Vaccines industry - Government policy Vaccines industry - Subsidies |
| Soggetto genere / forma | Legislative hearings. |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Altri titoli varianti | Examining Emergent Biosolutions' failure to protect public health and public funds |
| Record Nr. | UNINA-9910716651603321 |
| Washington : , : U.S. Government Publishing Office, , 2021 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
